Cefquinome Competitive Antibody Pair

AccuSift
CEQ
SKU Name Unit Price Delivery QTY
SR269 Cefquinome monoclonal antibody 1mg $700 10days
TC269 Cefquinome BSA antigen 1mg $266.6 10days
AccuSift provides high-performance cefquinome competitive assay pairings, characterized by exceptional batch-to-batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.
Cefquinome is the first fourth-generation cephalosporin antibiotic exclusively developed for veterinary use. As a β-lactam antimicrobial, it demonstrates high stability against β-lactamases and exhibits a broad spectrum of activity against pathogens including Actinobacillus pleuropneumoniaeand Glaesserella parasuis. It is clinically used for treating respiratory infections in swine and cattle, as well as bovine mastitis. The recommended intramuscular dosage is 3 mg per kilogram of body weight. The drug formulation includes cefquinome sulfate injection, which reaches peak plasma concentration approximately 1 hour post-intramuscular administration, with an elimination half-life of about 9 hours.
Performance Characteristics:
  • Sensitivity: ELISA IC50: 2 ppb; Colloidal Gold: 20 ppb

  • Source: Mouse Monoclonal Antibody

  • Purity: ≥ 90%

  • Recommended Pairing: (Coating) / (Labeling)

  • Storage: Long-term storage at ≤ –20°C; short-term storage at 2–8°C. Shipped on ice packs.

Operation

References